The Evolut™ PRO+ TAVR system features the lowest delivery profile for 23–29 mm valves and advanced sealing with an external tissue wrap on all valve sizes.

The Evolut™ FX transcatheter aortic valve replacement (TAVR) system sets new expectations for precision, control, and predictability in TAVR procedures.

Built on the original CoreValve TM platform, the Evolut™ FX+ valve is engineered with specific design elements to enable coronary access and promote sustained valve performance over time. 1,2 Performance as compared to Evolut™ PRO+ and FX system in bench testing.

The Evolut PRO+ system is the next-generation, self-expanding transcatheter aortic valve providing industry-leading hemodynamics.

Mar 27, 2024 · The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access.

The CoreValve and Evolut transcatheter aortic valve replacement (TAVR) devices have been evaluated in more than a dozen clinical trials. The studies provide consistent data establishing the safety and efficacy of the CoreValve system, and confirm its durability out to five years.

Learn about the Evolut R System, a Medtronic transcatheter aortic heart valve used in TAVI, a minimally invasive procedure to treat severe aortic stenosis.

Mar 10, 2025 · Conducted at over 80 sites worldwide, the study includes patients with an aortic valve annulus area of ≤430 mm who were suitable for transfemoral TAVR with either an Evolut PRO/PRO+/FX or a ...

Mar 10, 2025 · "The SMART Trial is a groundbreaking, head-to-head comparison that, for the first time, highlights how a patient with a small annulus can benefit from Evolut's differentiated valve design," said Kendra J. Grubb, M.D., M.H.A, M.Sc., vice president and chief medical officer, Structural Heart, which is part of the Cardiovascular Portfolio at ...

The Evolut™ FX transcatheter aortic valve replacement (TAVR) system sets new expectations for precision, control, and predictability in TAVR procedures.